857 :
451.
210330_analysts_conference.pdf
Analysts‘ Conference on FY2020 figures Dr. Stefan Wolf, CEO | Thomas Jessulat, CFO March 30, 2021 FY 2020 Headlines Top line decrease of -14.3% to EUR 1,480m, organically down by -11.7%, while…
452.
210506_q1_2021.pdf
Conference Call on Q1 2021 Dr. Stefan Wolf, CEO | Thomas Jessulat, CFO May 6, 2021 Q1 2021 Headlines Sales increased by 7.0% to EUR 424 million, organically up by 10.7% EBIT increased to EUR 48.4…
453.
210805_q2_2021_05.pdf
Conference Call on Q2 2021 Dr. Stefan Wolf, CEO | Thomas Jessulat, CFO August 5, 2021 Q2 2021 Headlines Recovery of sales after Covid-19 impact particularly on second quarter 2020 in Europe and…
454.
211104_q3_2021_04_0.pdf
Conference Call on Q3 2021 Dr. Stefan Wolf, CEO | Thomas Jessulat, CFO November 4, 2021 Q3 2021 Headlines Increase in revenues despite declining global LV production figures: regional growth…
456.
Legal Notes/Disclaimer
Legal Notes
Terms of use/Disclaimer
Whilst we took every possible care when we designed this website, ElringKlinger can not guarantee that it is current, correct or complete or be held…
457.
GTC
General Terms and Conditions
Terms and Conditions of Sale and Delivery (As of August 2022)
I. General information
These Terms and Conditions are a component of all contracts entered into…
458.
220329_-_elringklinger_-_analysts_conference_0.pdf
Analysts Conference FY 2021 figures March 29, 2022 FY 2021 Headlines Top line increase of 9.7% to EUR 1,624m, organically up by 10.1%, while global LV production increased by 3.4% EBIT increased…
459.
220505_elringklinger_-_q1_2022.pdf
Q1 2022 figures Dr. Stefan Wolf, CEO Thomas Jessulat, CFO May 5, 2022 Q1 2022 Headlines Group sales increased by 2.5% to EUR 434.6m, organically more or less unchanged with minus 0.1%, while…
460.
220804_elringklinger_-_q2_2022_0.pdf
Q2 2022 figures Dr. Stefan Wolf, CEO Thomas Jessulat, CFO August 4, 2022 Q2 2022 Headlines Difficult market environment: another lockdown in parts of China, ongoing war in Ukraine with uncertain…